Bruker Names Eicke Latz to Board of Directors
Bruker announced the appointment of Dr. Eicke Latz, an immunology leader and biopharma entrepreneur, to its Board of Directors effective January 1, 2027.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed